Previously, Mr. Bergy served as vice president of finance and chief accounting officer, vice president of finance for the medical division and corporate controller at Stryker.
He will be up for re-election in 2012.
Read the RTI Biologics release on Dean Bergy.
Read other coverage on RTI Biotics.
-RTI Biologics Develops Reimbursement Hotline for Sports Medicine
-RTI Biologics Posts 11% Higher Revenues in Third Quarter, a Record
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
